NEW ORLEANS – Dropping aspirin but keeping anticoagulation with apixaban and antiplatelet clopidogrel was effective and associated with less...
HONOLULU – The drug establishes good or excellent hemostasis in 82% of patients with acute major bleeding associated...
SEATTLE – Two studies detail the risk factors of first-time venous thromboembolism and heightened incidence of repeat VTE in patients with HIV.
PRAGUE – The biggest question for gene therapy today is durability, according to Dr. John Pasi.
WASHINGTON – The proteasome inhibitor carfilzomib increases risk for heart failure, and thalidomide analogs increase the risk for venous...
PRAGUE – The duration of treatment is more strongly linked to thromboembolism than dose magnitude, according to Dr. Andreas Tiede.
News from the FDA/CDC
The FDA is working with Pfizer to better understand how the signal affects patients and how the drug should be used, the agency said in a...
However, the reduction lost significance if treatment with rivaroxaban was halted.
SAN DIEGO – The procedure carries few risks, aside from patient discomfort.
The injection is approved in combination with plasma exchange and immunosuppressive therapy for adults with acquired thrombotic thrombocytopenia...